Rastogi N, Potar M C, Henrotte J G, Franck G, David H L
Service de la Tuberculose et des Mycobactéries, Institut Pasteur, Paris, France.
Zentralbl Bakteriol Mikrobiol Hyg A. 1988 Apr;268(2):251-8. doi: 10.1016/s0176-6724(88)80010-5.
Action of colistin (polymyxin E) was investigated on the opportunistic pathogenic species Mycobacterium avium ATCC 15769 (resistant strain, MIC greater than 100 micrograms/ml). Mycobacterium intracellulare ATCC 13950: a colistin-susceptible strain (MIC 25 micrograms/ml), was used as a parallel control for Mg++ efflux experiments. After the addition of 100 micrograms/ml of colistin to bacteria suspended in a buffer, both loss of viability and Mg++ efflux were followed for one week. Although there was an initial Mg++ efflux in both strains, it soon attained a plateau in case of the resistant strain without any loss of viability until 48 h, whereas in case of the susceptible strain, Mg++ efflux was about 3 times higher than former, a plateau was attained only 24 h after the drug addition, and the loss of viability started only 6 h after the drug addition. Consequently, the loss of viability of M. avium with later incubation times (6 days) was not due to the action of colistin on the cytoplasmic Mg++ efflux solely, but some additional effect was implicated. The drug-susceptibility of extracellularly-growing and intracellularly-growing (in the J-774 macrophage cell line) M. avium to the antibiotics tested could not be potentiated when they were used in combination with 5 micrograms/ml of colistin (maximal obtainable serum level in man) or the polymyxin B nonapeptide (PMBN), nor in the case of bacteria pretreated with these molecules.
研究了黏菌素(多黏菌素E)对机会致病性鸟分枝杆菌ATCC 15769(耐药菌株,MIC大于100微克/毫升)的作用。细胞内分枝杆菌ATCC 13950:一种对黏菌素敏感的菌株(MIC为25微克/毫升),用作镁离子外流实验的平行对照。向悬浮在缓冲液中的细菌中加入100微克/毫升黏菌素后,持续观察一周内细菌活力丧失和镁离子外流情况。虽然两种菌株最初都有镁离子外流,但耐药菌株很快达到平台期,在48小时内没有活力丧失,而敏感菌株的镁离子外流比前者高约3倍,在添加药物后仅24小时达到平台期,且在添加药物后仅6小时就开始出现活力丧失。因此,鸟分枝杆菌在较长培养时间(6天)时的活力丧失并非仅归因于黏菌素对细胞质镁离子外流的作用,而是涉及一些其他效应。当细胞外生长和细胞内生长(在J-774巨噬细胞系中)的鸟分枝杆菌与5微克/毫升黏菌素(人体可达到的最大血清水平)或多黏菌素B九肽(PMBN)联合使用时,或者在经这些分子预处理的细菌中,其对所测试抗生素的药敏性均未增强。